Back to Search
Start Over
New Pyrimidine and Pyridine Derivatives as Multitarget Cholinesterase Inhibitors: Design, Synthesis, and In Vitro and In Cellulo Evaluation.
- Source :
-
ACS chemical neuroscience [ACS Chem Neurosci] 2021 Nov 03; Vol. 12 (21), pp. 4090-4112. Date of Electronic Publication: 2021 Oct 15. - Publication Year :
- 2021
-
Abstract
- A new series of pyrimidine and pyridine diamines was designed as dual binding site inhibitors of cholinesterases (ChEs), characterized by two small aromatic moieties separated by a diaminoalkyl flexible linker. Many compounds are mixed or uncompetitive acetylcholinesterase (AChE) and/or butyrylcholinesterase (BChE) nanomolar inhibitors, with compound 9 being the most active on Electrophorus electricus AChE ( Ee AChE) ( K <subscript>i</subscript> = 0.312 μM) and compound 22 on equine BChE ( eq BChE) ( K <subscript>i</subscript> = 0.099 μM). Molecular docking and molecular dynamic studies confirmed the interaction mode of our compounds with the enzymatic active site. UV-vis spectroscopic studies showed that these compounds can form complexes with Cu <superscript>2+</superscript> and Fe <superscript>3+</superscript> and that compounds 18 , 20 , and 30 have antioxidant properties. Interestingly, some compounds were also able to reduce Aβ <subscript>42</subscript> and tau aggregation, with compound 28 being the most potent (22.3 and 17.0% inhibition at 100 μM on Aβ <subscript>42</subscript> and tau, respectively). Moreover, the most active compounds showed low cytotoxicity on a human brain cell line and they were predicted as BBB-permeable.
Details
- Language :
- English
- ISSN :
- 1948-7193
- Volume :
- 12
- Issue :
- 21
- Database :
- MEDLINE
- Journal :
- ACS chemical neuroscience
- Publication Type :
- Academic Journal
- Accession number :
- 34652128
- Full Text :
- https://doi.org/10.1021/acschemneuro.1c00485